Osmotic blood-brain barrier modification: clinical documentation by enhanced CT scanning and/or radionuclide brain scanning

AJR. American Journal of Roentgenology
E A NeuweltE P Frenkel

Abstract

Results of initial clinical trials of brain tumor chemotherapy after osmotic blood-brain barrier disruption are promising. In general, the procedure is well tolerated. The major complication has been seizures. In this report, data are presented which indicate that the etiology of these seizures is related to the use of contrast agent (meglumine iothalamate) to monitor barrier modification. A series of 19 patients underwent a total of 85 barrier modification procedures. Documentation of barrier disruption was monitored by contrast-enhanced computed tomographic (CT) scanning, radionuclide brain scanning, or a combination of both techniques. In 56 procedures (19 patients) monitored by enhanced CT, seizures occurred a total of 10 times in eight patients. Twenty-three barrier modification procedures (in nine of these 19 patients) documented by nuclear brain scans alone, however, resulted in only one focal motor seizure in each of two patients. In eight of the 19 patients who had seizures after barrier disruption and enhanced CT scan, four subsequently had repeat procedures monitored by radionuclide scan alone. In only one of these patients was further seizure activity noted; a single focal motor seizure was observed. Clearly, the ra...Continue Reading

Citations

Jun 1, 1988·Cancer Metastasis Reviews·R A Hawkins, M E Phelps
Feb 1, 1993·Journal of Neuro-oncology·Y IwadateK Sueyoshi
Jun 1, 1986·Italian Journal of Neurological Sciences·M GaspariniR Sterzi
Feb 27, 2007·Epilepsia·Nicola MarchiDamir Janigro
Sep 16, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Aaron J CarmanMargaret S Bynoe
Jan 3, 2013·Annals of Neurology·Richard Daneman
Feb 26, 2005·Pediatric Neurology·Richard E FryeMustafa Sahin
Jan 1, 1991·International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology·A SinghM K Gumerlock
Mar 1, 1989·Cancer Treatment Reviews·D J Stewart, W K Evans
Jan 1, 1985·Seminars in Nuclear Medicine·R P Spencer
Sep 4, 2015·Fluids and Barriers of the CNS·Margaret S BynoeDo-Geun Kim
Nov 23, 2006·Epilepsia·Emily Oby, Damir Janigro
Oct 19, 2011·Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences·J-K BurkhardtJ A Boockvar
Feb 6, 2021·Neuro-oncology Advances·Ashley GhiaseddinStuart A Grossman
Apr 29, 2021·Proceedings of the National Academy of Sciences of the United States of America·Scott R BurksJoseph A Frank

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.